Account Manager - Cutaneous Oncology - Plano, TX

Title: Account Manager - Cutaneous Oncology - Plano, TX Date: May 5, 2026 Location: FS - Sun Company: Sun Pharmaceutical Industries, Inc (USA) The Account Manager – Cutaneous Oncology is a field‑based sales role responsible for driving demand and market share growth for Odomzo® and Unloxcyt™ within an assigned territory. This individual will build and maintain strong relationships with oncologists, dermatologists, Mohs surgeons, and key stakeholders in community and academic settings. The Account Manager will be accountable for developing strategic business plans, executing sales initiatives, and ensuring optimal patient access to therapy. This role requires a deep understanding of the cutaneous oncology landscape, buy‑and‑bill model, infusion logistics, and a collaborative mindset to partner cross‑functionally across Market Access, Medical Affairs, and other field teams. Key Responsibilities Promote Odomzo and Unloxcyt to appropriate healthcare providers, including dermatologists, oncologists, and other key decision‑makers. Educate customers on clinical data, product benefits and the differentiated mechanisms of action, including PD‑L1 blockade and Fc effector function, and ADCC. Execute territory business plans, including strategic targeting and customer engagement tactics. Identify and develop advocates and early adopters to support product growth. Navigate complex office‑ and hospital‑based pathways to support buy‑and‑bill, reimbursement and access. Collaborate with internal stakeholders including Market Access, Field Reimbursement Managers and Medical Science Liaisons. Attend and support relevant local and national conferences, speaker programs and educational events. Track and analyze territory performance data and adjust tactics as needed to achieve sales goals. Ensure full compliance with all company policies, procedures, and applicable laws and regulations. Qualifications Required: Minimum 3 years of pharmaceutical, biotech or medical device sales experience preferred Demonstrated success in specialty sales, preferably in oncology or dermatology Proven ability to operate in a complex environment with multiple stakeholders Strong understanding of reimbursement, specialty pharmacy and infusion channel dynamics Excellent communication, negotiation and presentation skills Ability to travel extensively within the territory Preferred: Experience launching new oncology or dermatology products Knowledge of Hedgehog Pathway Inhibitors and/or PD‑L1 immunotherapies Existing relationships with dermatology oncologists or Mohs surgeons Strategic territory management Clinical acumen and ability to simplify complex science Customer‑centric mindset Cross‑functional collaboration Integrity and accountability Resilience and adaptability Compensation & Benefits The base compensation pay range for this position is $115,000 to $175,000. Actual base compensation may vary based on a number of factors, including but not limited to geographical location and experience. This position is part of an IC Commission Plan and is eligible for the receipt of a company vehicle. Employees are eligible to participate in company benefit programs which include medical, dental and vision coverage; life insurance; disability insurance; 401(k) savings plan; flexible spending accounts; and the employee assistance program. Employees also receive various paid time off benefits, including vacation time and sick time. EEO Statement We provide equal employment opportunities for all current employees and applicants for employment. This policy means that no one will be discriminated against because of race, religion, creed, color, national origin, nationality, citizenship, ancestry, sex, age, marital status, physical or mental disability, affectionate or sexual orientation, military or veteran status, generic predisposing characteristics or any other basis prohibited by law. Employees will be in an “at‑will” position and the company reserves the right to modify base salary (as well as any other discretionary payment or compensation program) at any time. #J-18808-Ljbffr Sun Pharmaceutical Industries, Inc.